Skip to main content

Active filters: News (16 posts)

Clear filters
The First FDA Warning Letter Referencing AI: Why the Failure Was Not the Technology, but the Lack of Control
News Pinned

The First FDA Warning Letter Referencing AI: Why the Failure Was Not the Technology, but the Lack of Control

The first FDA Warning Letter explicitly referencing the use of Artificial Intelligence is making waves across the industry. But a closer look reveals: the failure was not the technology itself, but the lack of control around it. Missing validation, insufficient documentation, and poor process integration — the actual weaknesses are well-known GMP issues.

Warning Letter analyzed in detail
Andreas Nicklas, CEO anic GmbH, im Interview mit der phpro über pragmatische Digitalisierung in der Pharmaproduktion
News Pinned

We're featured in phpro – Interview with Andreas Nicklas

Yes — we're featured in phpro. And most importantly: we're not only addressing those who are already producing in a fully digital environment. In practice, a large number of pharmaceutical manufacturers — around 60–70% — are still working with paper-based batch documentation. That is exactly why the interview with Andreas Nicklas is worth reading: it explores how to approach the move toward digitalization in a pragmatic way — and why change must never become a bottleneck in the process.

Read article

Page 1 of 2